Robert R. Seltzer serves as Executive at NephroGenex, Inc., where they oversee executive responsibilities. Since joining the company, Robert R. Seltzer has executed 4 insider transactions totaling $9.5M, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 14, 2014 involved receiving (via award) 412,592 shares valued at $0.
Robert R. Seltzer currently holds 3,451,097 shares of NephroGenex, Inc. (NRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert R. Seltzer has been a net buyer of NRX stock. They have purchased $9.5M and sold $0 worth of shares.
Robert R. Seltzer's most recent insider trade was on Feb 14, 2014, when they sold 412,592 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 14, 2014 | NRX | $0 | Conversion | 890,140 | $N/A | Discretionary |
| Feb 14, 2014 | NRX | $9.5M | Purchase | 790,000 | $12.00 | Discretionary |